Form 4: Ralph Alvarez Acquires Eli Lilly Shares Under Directors' Deferral Plan

Director Ralph Alvarez acquired 14.364 shares of Eli Lilly & Co common stock at $818.02 per share under the Lilly Directors' Deferral Plan.

Summary

• Ralph Alvarez, a director of Eli Lilly & Co, acquired 14.364 shares of common stock on April 21, 2025.
• The shares were acquired at a price of $818.02 per share.
• The acquisition was made under the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation.
• These shares will be settled in common stock following Alvarez's separation from service.
• Following the transaction, Alvarez beneficially owns 54,847.135 shares of Eli Lilly common stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a director's continued investment in the company, which is generally viewed favorably, but it's also a routine transaction.

Positives

• The acquisition reflects a continued investment in Eli Lilly by a member of its board of directors.
• The Lilly Directors' Deferral Plan allows directors to align their interests with the long-term performance of the company.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This filing is a routine disclosure of a director's stock acquisition, which is common in publicly traded companies. It reflects standard compensation practices for board members.

Comparison to Industry Standards

• Director compensation packages often include stock options or deferred stock units to align director interests with shareholder value, similar to practices at companies like Pfizer (PFE) and Johnson & Johnson (JNJ).
• Deferred compensation plans for directors are a common practice, ensuring long-term commitment and alignment with company performance, comparable to plans offered by Merck (MRK) and AbbVie (ABBV).

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a board member.
• The deferral plan aligns the director's interests with the long-term success of the company, benefiting shareholders.

Key Dates

Keywords

Eli Lilly, LLY, Ralph Alvarez, Director, Stock Acquisition, Directors' Deferral Plan, Form 4, Beneficial Ownership